Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.57M Sell
91,537
-2,187
-2% -$58.2K 0.25% 84
2025
Q4
$2.33M Buy
93,724
+2,379
+3% +$60K 0.23% 78
2025
Q3
$2.33M Buy
91,345
+26,318
+40% +$650K 0.24% 79
2025
Q2
$1.58M Buy
65,027
+10,437
+19% +$243K 0.18% 116
2025
Q1
$1.38M Buy
54,590
+7,199
+15% +$188K 0.17% 121
2024
Q4
$1.26M Sell
47,391
-4,149
-8% -$113K 0.15% 134
2024
Q3
$1.49M Buy
51,540
+1,780
+4% +$51.9K 0.18% 114
2024
Q2
$1.39M Sell
49,760
-2,478
-5% -$68.2K 0.18% 110
2024
Q1
$1.45M Buy
52,238
+14,436
+38% +$401K 0.19% 114
2023
Q4
$1.09M Sell
37,802
-6,216
-14% -$188K 0.15% 131
2023
Q3
$1.46M Buy
44,018
+2,825
+7% +$99.9K 0.23% 92
2023
Q2
$1.51M Buy
41,193
+509
+1% +$19.8K 0.23% 95
2023
Q1
$1.66M Sell
40,684
-2,492
-6% -$108K 0.27% 80
2022
Q4
$2.21M Buy
43,176
+6,162
+17% +$295K 0.39% 47
2022
Q3
$1.62M Sell
37,014
-644
-2% -$31.3K 0.32% 59
2022
Q2
$1.98M Buy
37,658
+3,485
+10% +$178K 0.38% 53
2022
Q1
$1.77M Buy
34,173
+3,660
+12% +$190K 0.36% 54
2021
Q4
$1.8M Sell
30,513
-644
-2% -$31.9K 0.36% 54
2021
Q3
$1.34M Sell
31,157
-14,371
-32% -$637K 0.3% 69
2021
Q2
$1.78M Buy
45,528
+992
+2% +$38.6K 0.42% 49
2021
Q1
$1.61M Sell
44,536
-3,533
-7% -$125K 0.45% 46
2020
Q4
$1.77M Buy
48,069
+2,665
+6% +$97.8K 0.52% 37
2020
Q3
$1.58M Buy
45,404
+11,207
+33% +$393K 0.57% 35
2020
Q2
$1.06M Sell
34,197
-6,203
-15% -$211K 0.42% 60
2020
Q1
$1.25M Sell
40,400
-4,260
-10% -$145K 0.67% 30
2019
Q4
$1.66M Buy
+44,660
New +$1.59M 1.18% 30

Other funds holding PFE

Wealth Alliance's PFE Position: Q1 2026 in Review

Wealth Alliance reduced its Pfizer (PFE) stake by 2.3% in Q1 2026, selling an estimated $58.2K and leaving 91,537 shares worth $2.57M. The position accounts for 0.25% of the portfolio, ranked #84.

Wealth Alliance first reported a position in PFE in Q4 2019 and has held it in 26 quarters since. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Wealth Alliance held 91,537 shares of Pfizer worth $2.57M as of Q1 2026.
  • Wealth Alliance sold 2,187 Pfizer shares in Q1 2026, an estimated $58.2K.
  • Pfizer made up 0.25% of Wealth Alliance's portfolio in Q1 2026, its #84 holding.
  • Wealth Alliance first reported a position in Pfizer in Q4 2019 and has held it in 26 quarters since.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Wealth Alliance's 13F filing for Q1 2026, filed 14 May 2026.